journal article·2015-11

Determination of silver in personal care nanoproducts and effects on dermal exposure

Nootcharin Wasukan, Sujittra Srisung, Kornphimol Kulthong, Suwimon Boonrungsiman, Rawiwan Maniratanachote

Journal of Nanoparticle Research· Volume 17· Issue 11
Publisher page

Abstract

Silver (Ag) is one of the widely used nanomaterials in cosmetics, personal care, and household products. This research aimed to investigate the Ag concentration contained in 20 commercial nanoproducts using a simple and reliable procedure. The exposure and adverse effects of a single topical application of Ag on the skin were also evaluated. Herein, we demonstrated that the technique of wet acid digestion, extraction and detection of Ag with graphite furnace absorption spectrometry were effective for any and all nanoproduct matrices. The Ag morphology was characterized by scanning and transmission electron microscopy equipped with energy-dispersive x-ray spectroscopy. Penetration of Ag was evaluated using a polyethersulfone (PES) membrane through a Franz cell and reconstructed human epidermis (RhE) tissue. A skin irritation test was performed on RhE, an acceptable in vitro model which was in compliance with OECD test guideline 439. The results showed that the initial Ag concentration in the tested nanoproducts ranged between 0.0058 and 94 µg/g. However, particulate Ag was only found in two products, both of a liquid formulation. Silver penetration through a PES membrane (0.12–53 % by weight) was weakly correlated with the initial Ag concentration in each sample, but more so to the product formulation. The liquid products demonstrated the highest percent of average Ag penetration, followed by the semi-solid and solid formulations, respectively. In contrast, neither any Ag diffusion from these products into the RhE tissue nor any irritation or toxicity was detected. This study suggests a screening method to evaluate the Ag level in products and their potential adverse effects on the skin that could be incorporated as a part of risk assessment for nanotechnology products.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Contact Dermatitis and Allergies · Heavy Metal Exposure and Toxicity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Chattaraj SC, Swarbrick J, Kanfer I (1995) A simple diffusion cell to monitor drug release from semi-solid dosage forms. Int J Pharm 120:119–12410.1016/0378-5173(94)00426-6 ↗
2. Chen X, Schluesener HJ (2008) Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1–1210.1016/j.toxlet.2007.10.004 ↗
3. Chung IS, Lee MY, Shin DH, Jung HR (2010) Three systemic argyria cases after ingestion of colloidal silver solution. Int J Dermatol 49:1175–117710.1111/j.1365-4632.2009.04380.x ↗
4. Ciaralli L, Giordano R, Cassina S, Sepe A, Costantini S (1996) Determination of chromium and nickel in commercial foam bath products by ETA-AAS. Ist Super di Sanita 32:381–385
5. Dastjerdi R, Montazer M (2010) A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. Colloids Surf, B 79:5–1810.1016/j.colsurfb.2010.03.029 ↗
6. Drake PL, Hazelwood KJ (2005) Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg 49:575–58510.1093/annhyg/mei019 ↗
7. EPA (2012) 2012 Edition of the drinking water standards and health advisories. Information on the web-site: http://water.epa.gov/action/advisories/drinking/upload/dwstandards2012.pdf . Accessed 10 Apr 2012
8. Fubini B, Ghiazza M, Fenoglio I (2010) Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 4:347–36310.3109/17435390.2010.509519 ↗
9. Gabbanini S, Matera R, Beltramini C, Minghetti A, Valgimigli L (2010) Analysis of in vitro release through reconstructed human epidermis and synthetic membranes of multi-vitamins from cosmetic formulations. J Pharm Biomed Anal 52:461–46710.1016/j.jpba.2010.01.029 ↗
10. Garcias-Ladaria J, Hernandez-Bel P, Torregrosa-Calatayud JL, Martínez-Aparicio A (2013) Argiria cutánea localizada. A propósito de 2 casos. Actas Dermosifiliogr 104:254–25510.1016/j.ad.2012.03.013 ↗
11. Geiss O, Cascio C, Gilliland D, Franchini F, Barrero-Moreno J (2013) Size and mass determination of silver nanoparticles in an aqueousmatrix using asymmetric flow field flow fractionation coupled to inductively coupled plasma mass spectrometer andultraviolet–visible detectors. J Chromatogr A 1321:100–10810.1016/j.chroma.2013.10.060 ↗
12. Hansen SF, Michelson ES, Kamper A, Borling P, Stuer-Lauridsen F, Baun A (2008) Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 17:438–44710.1007/s10646-008-0210-4 ↗
13. Henkler F, Tralau T, Tentschert J, Kneuer C, Haase A, Platzek T, Luch A, Götz ME (2012) Risk assessment of nanomaterials in cosmetics: a European union perspective. Arch Toxicol 86:1641–164610.1007/s00204-012-0944-x ↗
14. Ilić V, Šaponjić Z, Vodnik V, Potkonjak B, Jovančić P, Nedeljković J, Radetić M (2009) The influence of silver content on antimicrobial activity and color of cotton fabrics functionalized with Ag nanoparticles. Carbohydr Polym 78:564–56910.1016/j.carbpol.2009.05.015 ↗
15. Jiang JK, Oberdorster G, Biswas P (2009) Characterization of size, surface charge and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–8910.1007/s11051-008-9446-4 ↗
16. Lademann J, Otberg N, Jacobi U, Hoffman RM, Blume-Peytavi U (2005) Follicular penetration and targeting. J Investig Dermatol Symp Proc 10:301–30310.1111/j.1087-0024.2005.10121.x ↗
17. Larese FF, D’Agostin F, Crosera M, Adamib G, Renzi N, Bovenzi M, Maina G (2009) Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255:33–3710.1016/j.tox.2008.09.025 ↗
18. Lekki J, Stachura Z, Dabros W, Stachura J, Menzel F, Reinert T, Butz T, Pallon Jan LU, Gontier E, Ynsa MD, Moretto P, Kertesz Z, Szikszai Z, Kiss AZ (2007) On the follicular pathway of percutaneous uptake of nanoparticles: ion microscopy and autoradiography studies. Nucl Instrum Meth Phys Res B 260:174–17710.1016/j.nimb.2007.02.021 ↗
19. Loeschner K, Navratilova J, Legros S, Wagner S, Grombe R, Snell J, von der Kammer F, Larsen EH (2013) Optimization and evaluation of asymmetric flow field-flow fractionation of silver nanoparticles. J Chromatogr 1272:116–12510.1016/j.chroma.2012.11.053 ↗
20. McKenna JK, Hull CM, Zone JJ (2003) Argyria associated with colloidal silver supplementation. Int J Dermatol 42:54910.1046/j.1365-4362.2003.01899.x ↗
21. Monteiro-Riviere NA, Inman AO, Snider TH, Blank JA, Hobson DW (1997) Comparison of an in vitro skin model to normal human skin for dermatological research. Microsc Res Tech 37:172–17910.1002/(SICI)1097-0029(19970501)37:3<172::AID-JEMT2>3.0.CO;2-Q ↗
22. NANOTEC (2012) The nanosafety and ethics strategic plan (2012–2016). Information on the web-site: http://www.nanotec.or.th/en/wp-content/uploads/2012/02/The-Nanosafety-and-Ethics-Strategic-Plan.pdf . Accessed 20 Feb 2012
23. Nowack B, Krug HF, Height M (2011) 120 Years of nanosilver history: implications for policy makers. Environ Sci Technol 45:1177–118310.1021/es103316q ↗
24. OSHA (2013) OSHA fact sheet: working safely with nanomaterials US department of labor-occupational safety and health administration. Information on the web-site: https://www.osha.gov/Publications/OSHA_FS-3634.pdf . Accessed 15 Jan 2013
25. Otto A, du Plessis J, Wiechers JW (2009) Formulation effects of topical emulsions on transdermal and dermal delivery. Int J Cosmet Sci 31:1–1910.1111/j.1468-2494.2008.00467.x ↗
26. Ponec M, Boelsma E, Weerheim A, Mulder A, Bouwstra J, Mommaas M (2000) Lipid and ultrastructural characterization of reconstructed skin models. Int J Pharm 203:211–22510.1016/S0378-5173(00)00459-2 ↗
27. Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Hackbarth S, Kembuan C, Blume-Peytavi U, Ru¨hl E, Lademann J, Vogt A (2012) Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization and colloidal stability. ACS Nano 6:6829–684210.1021/nn301622h ↗
28. Ryman-Rasmussen JP, Riviere JE, Monteire-Riviere NA (2006) Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91:159–16510.1093/toxsci/kfj122 ↗
29. Salata OV (2004) Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:1–610.1186/1477-3155-2-1 ↗
30. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA (2010) Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 118:407–41310.1289/ehp.0901398 ↗
31. SCCS (2012) Guidance on the safety assessment of nanomaterials in cosmetics SCCS/1484/12. Information on the web-site: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_005.pdf . Accessed 20 Jan 2012
32. Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem JH, Eskes C, Roguet R, Cotovio J, Cole T, Worth A, Heylings J, Jones P, Robles C, Kandárová H, Gamer A, Remmele M, Curren R, Raabe H, Cockshott A, Gerner I, Zuang V (2007) The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the skin integrity function test. Altern Lab Anim 35:559–60110.1177/026119290703500614 ↗
33. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U (2004) Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 123:168–17610.1111/j.0022-202X.2004.22717.x ↗
34. Tulve NS, Stefaniak AB, Vance ME, Rogers K, Mwilu S, LeBouf RF, Schwegler-Berry D, Willis R, Thomas TA, Marr LC (2015) Characterization of silver nanoparticles in selected consumer products and its relevance for predicting children’s potential exposures. Int J Hyg Environ Health 218:345–35710.1016/j.ijheh.2015.02.002 ↗
35. U.S. FDA (2014) Guidance for industry: Safety of nanomaterials in cosmetic products. Information on the web-site: http://www.fda.gov/Cosmetics/GuidanceRegulation/GuidanceDocuments/ucm300886.htm . Accessed 9 June 2014
36. Wilkinson SC, Maas WJ, Nielsen JB, Greaves LC, van de Sandt JJ, Williams FM (2006) Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies. Int Arch Occup Environ Health 79:405–41310.1007/s00420-005-0056-5 ↗